N Verses Capital, LLC Exelixis, Inc. Put Options Transaction History
N Verses Capital, LLC
- $219 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
465Shares Held
240MCall Options Held
1.87MPut Options Held
1.12M-
Black Rock Inc. New York, NY33.5MShares$1.2 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$1.06 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$970 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$543 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$451 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.5B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...